Hanmi Science (008930) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hanmi Science (008930) has a cash flow conversion efficiency ratio of 0.011x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.12 Billion ≈ $6.86 Million USD) by net assets (₩959.19 Billion ≈ $650.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hanmi Science (008930) liquidity interval to measure how many days the company can operate on defensive assets alone.
Hanmi Science - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Hanmi Science's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hanmi Science Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hanmi Science ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HIAG Immobilien Holding AG
SW:HIAG
|
0.015x |
|
Shanghai Environment Group Co Ltd
SHG:601200
|
0.037x |
|
RHI Magnesita NV
VI:RHIM
|
0.134x |
|
Zillow Group Inc
NASDAQ:ZG
|
0.045x |
|
Harrow Health Inc
NASDAQ:HROW
|
-0.317x |
|
Jiangsu Wujiang Rural Coml Bk
SHG:603323
|
-0.276x |
|
J & J Snack Foods Corp
NASDAQ:JJSF
|
0.018x |
|
Jiangsu Rongtai Industry Co. Ltd.
SHG:605133
|
0.029x |
Annual Cash Flow Conversion Efficiency for Hanmi Science (2000–2025)
The table below shows the annual cash flow conversion efficiency of Hanmi Science from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see Hanmi Science (008930) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩959.19 Billion ≈ $650.03 Million |
₩47.66 Billion ≈ $32.30 Million |
0.050x | -49.79% |
| 2024-12-31 | ₩838.70 Billion ≈ $568.38 Million |
₩82.99 Billion ≈ $56.24 Million |
0.099x | +121.62% |
| 2023-12-31 | ₩787.47 Billion ≈ $533.66 Million |
₩35.16 Billion ≈ $23.83 Million |
0.045x | +242.35% |
| 2022-12-31 | ₩724.75 Billion ≈ $491.15 Million |
₩9.45 Billion ≈ $6.41 Million |
0.013x | -34.24% |
| 2021-12-31 | ₩690.29 Billion ≈ $467.80 Million |
₩13.69 Billion ≈ $9.28 Million |
0.020x | -5.45% |
| 2020-12-31 | ₩658.73 Billion ≈ $446.41 Million |
₩13.82 Billion ≈ $9.36 Million |
0.021x | +3.99% |
| 2019-12-31 | ₩645.69 Billion ≈ $437.57 Million |
₩13.02 Billion ≈ $8.83 Million |
0.020x | +387.66% |
| 2018-12-31 | ₩653.09 Billion ≈ $442.59 Million |
₩2.70 Billion ≈ $1.83 Million |
0.004x | +108.17% |
| 2017-12-31 | ₩665.15 Billion ≈ $450.76 Million |
₩-33.68 Billion ≈ $-22.83 Million |
-0.051x | -142.85% |
| 2016-12-31 | ₩647.56 Billion ≈ $438.84 Million |
₩76.52 Billion ≈ $51.86 Million |
0.118x | +47.12% |
| 2015-12-31 | ₩584.25 Billion ≈ $395.94 Million |
₩46.93 Billion ≈ $31.80 Million |
0.080x | +539.61% |
| 2014-12-31 | ₩417.71 Billion ≈ $283.08 Million |
₩5.25 Billion ≈ $3.55 Million |
0.013x | +2287.90% |
| 2013-12-31 | ₩409.07 Billion ≈ $277.22 Million |
₩-234.79 Million ≈ $-159.11K |
-0.001x | -100.95% |
| 2010-12-31 | ₩604.83 Billion ≈ $409.88 Million |
₩36.49 Billion ≈ $24.73 Million |
0.060x | -55.95% |
| 2009-12-31 | ₩444.88 Billion ≈ $301.49 Million |
₩60.93 Billion ≈ $41.29 Million |
0.137x | +31.54% |
| 2008-12-31 | ₩393.00 Billion ≈ $266.33 Million |
₩40.92 Billion ≈ $27.73 Million |
0.104x | -48.66% |
| 2006-12-31 | ₩291.16 Billion ≈ $197.32 Million |
₩59.05 Billion ≈ $40.02 Million |
0.203x | -4.83% |
| 2005-12-31 | ₩219.66 Billion ≈ $148.86 Million |
₩46.81 Billion ≈ $31.72 Million |
0.213x | +53.31% |
| 2004-12-31 | ₩181.81 Billion ≈ $123.21 Million |
₩25.27 Billion ≈ $17.13 Million |
0.139x | -4.75% |
| 2003-12-31 | ₩155.62 Billion ≈ $105.46 Million |
₩22.71 Billion ≈ $15.39 Million |
0.146x | -34.08% |
| 2002-12-31 | ₩146.43 Billion ≈ $99.23 Million |
₩32.42 Billion ≈ $21.97 Million |
0.221x | -22.75% |
| 2001-12-31 | ₩131.69 Billion ≈ $89.25 Million |
₩37.74 Billion ≈ $25.58 Million |
0.287x | +39.40% |
| 2000-12-31 | ₩90.93 Billion ≈ $61.62 Million |
₩18.69 Billion ≈ $12.67 Million |
0.206x | -- |
About Hanmi Science
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition… Read more